DGM
INBX

Darwin Global Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Darwin Global Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-591,975
Closed -$25.9M – 13
2021
Q4 		$25.9M Buy
591,975
+49,389
+9% +$1.98M 3.95% 4
2021
Q3 		$18.1M Buy
542,586
+317,106
+141% +$9.65M 3.33% 5
2021
Q2 		$6.21M Buy
225,480
+175,771
+354% +$3.66M 1% 7
2021
Q1 		$998K Buy
49,709
+13,175
+36% +$385K 0.2% 11
2020
Q4 		$1.21M Buy
+36,534
New +$972K 0.34% 10

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Darwin Global Management's INBX Position: Q1 2022 in Review

Darwin Global Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2022, closing a stake of 591,975 shares — an estimated $25.9M sold.

Darwin Global Management first reported a position in INBX in Q4 2020 and held it in 5 quarters. The position peaked at $25.9M in Q4 2021. 99 funds tracked by Wall St. Rank hold INBX as of Q1 2022.

  • Darwin Global Management reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Darwin Global Management sold 591,975 Inhibrx, Inc. Common Stock shares in Q1 2022, an estimated $25.9M.
  • Darwin Global Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Darwin Global Management's Inhibrx, Inc. Common Stock position peaked at $25.9M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2022.

Based on Darwin Global Management's 13F filing for Q1 2022, filed 16 May 2022.